Introduction {#s1}
============

The majority of idiopathic right ventricular arrhythmias (VAs), including idiopathic premature ventricular contractions (PVCs) and ventricular tachycardias (IVTs), originate from the right ventricular outflow tract (RVOT), with a small part of them originating from the inflow, free wall, or apex of the right ventricle [@pone.0067038-Coggins1]--[@pone.0067038-Navarrete1]. Idiopathic PVCs and VTs originating from the right ventricular (RV) septum are rare. Only few cases of idiopathic VAs have been reported to originate from the subtricuspid septum and near the His bundle [@pone.0067038-Satish1]--[@pone.0067038-Yamauchi1]. However, little is known about the prevalence, distribution, electrocardiographic (ECG) characteristics and the efficacy of radiofrequency catheter ablation (RFCA) for the VAs arising from the RV septum. The purpose of this study was to analyze the ECG characteristics and the outcome of catheter ablation for such PVCs/IVTs originating from the RV septum.

Methods {#s2}
=======

Study Population {#s2a}
----------------

From July 2006 to January 2012, a total of 581 patients (250 men and 331 women; age 46.9±17.2 years \[mean±SD\] ) without structural heart disease were presented for catheter ablation for PVCs/IVTs in our hospital. Twenty-nine of the 581 patients were found to have idiopathic PVCs/IVTs originating from the RV septum and are the focus of the present study. All patients were verified as having no structural heart disease, including coronary artery disease, valvular heart disease, congenital heart disease, left ventricle hypertrophy, and right ventricle abnormalities by routine biochemistry tests, X-ray, color echocardiography examination, exercise electrocardiogram testing, magnetic resonance imaging (MRI), and/or cardiac catheterization with coronary angiography or RV contrast angiography. Before RFCA, a 12-lead ECG was obtained, and 24 h of ambulatory ECG monitoring (Holter) was carried out at least once. The ECG was monitored for 24 h just before catheter ablation. The 29 patients with idiopathic PVCs/IVTs from the RV septum were compared with a randomly chosen series of 125 patients with idiopathic PVCs/IVTs in whom the site of origin was in the RVOT (n = 87, 56 women and 31 men; age 48.1±17.2 years) or the RV free wall (n = 38, 13 women and 25 men; age 36.2±17.7 years). A pace mapping study was also performed in 10 control subjects (6 women and 4 men; age 37.6±15.1 years) without structural heart disease after successful ablation of their original atrioventricular nodal reentrant tachycardia to determine the ECG characteristics of idiopathic PVCs/IVTs originating from the RV septum.

Ethics Approval {#s2b}
---------------

Ethical approval was obtained from the Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical College, and All participants consented to the experimental procedures. Written informed consent was obtained from each participant.

Inclusion Criteria {#s2c}
------------------

The selection criteria of patients were the following reasons : (1) frequent or consecutive PVC occurrence, the average PVC count ≥10000/24 h; (2) inability of the patient to tolerate PVCs/IVTs or unsuccessful treatment with at least one antiarrhythmic drug; (3) no structural heart disease; and (4) consent for the catheter ablation procedure.

Electrophysiologic Study and RFCA {#s2d}
---------------------------------

Anti-arrhythmic drugs were withdrawn in all patients at least five half-lives before ablation, with the exception of amiodarone that was withdrawn eight weeks before intervention. Standard multielectrode catheters were inserted and positioned in the RV apex, RVOT, and His-bundle region through femoral veins under fluoroscopic guidance. A programmed electrical stimulation was performed from the RV apex and RVOT at basic drive cycle lengths of 600, 500, and 430 ms, delivering a maximum of three extrastimuli. If the clinical arrhythmia did not occur spontaneously and was not induced at baseline, intravenous isoproterenol (2--4 µg/min) was administered to induce arrhythmia. A 12-lead surface ECG was monitored and recorded on a multichannel oscilloscopic recorder**.** Detailed endocardial activation mapping and pace mapping were performed using an 8F quadripolar catheter with a deflectable tip and a 4-mm distal electrode. If the ventricular electrograms from the RV septum were the earliest of the entire RV endocardial mapping sites, we occasionally mapped the aortic valve cusps.

The target site for RFCA was determined by activation mapping (earliest local activation time preceding the earliest surface QRS by ≥20 msec) in patients with frequent PVCs/sustained IVT, and by pace mapping (≥11/12--lead concordance of major and minor deflections between the pace map and the clinical PVCs) in those with infrequent arrhythmia. After the target site was located, RFCA was applied in all patients by using irrigated-tip catheter (43°C, 30 W, 20 ml/min) with the three-dimensional mapping (Ensite NavX system or Carto XP or Carto 3 system) or a conventional catheter under temperature control (target temperature 55°C, and starting power of 20 W with gradual titration to a maximum power of 50 W). If the PVCs/IVTs terminated within 10 s of ablation, or if they increased in frequency within the initial 10 s of ablation, additional current was applied for another 60 to 180 s. If PVCs/IVTs did not terminate within 10 s, the radiofrequency energy application was terminated and another target site was sought. Acute procedural successful ablation was defined as complete elimination of spontaneous or inducible VAs. Programmed electrical stimulation was repeated at 30 min after the last application of radiofrequency energy to confirm the absence of inducible VAs before removing all catheters and sheaths. If the site demonstrating a perfect pace map was exactly where the largest His bundle potential was recorded, RF ablation could not be applied in order to avoid atrioventricular nodal block. If the best pace mapping site was close to the His bundle, the RF energy was cautiously delivered starting with a low power setting at the site that was at least 5 mm away from the recording site of the largest His bundle potential.

Definition of PVCs/IVTs Originating from the RV Septum {#s2e}
------------------------------------------------------

To facilitate the identification of region-specific ECG features that might suggest an RV septum origin, sites of origin of PVCs/IVTs in the RV septum from top to bottom of the RV septum were grouped into distinct anatomic segments: superoseptum (from top to the His bundle), midseptum (from the His bundle to coronary sinus), and inferoseptum (from the coronary sinus to bottom) ([Figure 1](#pone-0067038-g001){ref-type="fig"}). The His bundle region was determined as the site recording the largest His bundle potential. The RV septum was further divided into three regions: a valvular region extending from the tricuspid valve to 2 cm anterior of the valve, and two equal portions between this region and the RV apex (basal and apical region), as previously reported [@pone.0067038-VanHerendael1], [@pone.0067038-Bazan1]. Therefore, we defined 9 distinct anatomic segments ([Figure 1A](#pone-0067038-g001){ref-type="fig"}). We localized the origin of PVCs/IVTs within the RV septum with fluoroscopy and by creating a electroanatomic map of the RV chamber in many patients: 1) the tip of the catheter crossed the tricuspid valve when observed in the right anterior oblique (RAO) view at the ablation site, and directed toward the RV septum when observed in the left anterior oblique (LAO) view at the ablation site; 2) When PVCs/IVTs originated from the tricuspid valvular RV septum regions, the ratio of the atrial to ventricular electrograms at the ablation site was \<1, and the amplitudes of the atrial and ventricular electrograms were≧0.03 and \>0.35 mV at the ablation site, respectively; 3) When PVCs/IVTs originated from the basal and apical regions of RV septum, only local ventricular electrograms and no atrial electrograms at the ablation site were recorded.

![Schematic left lateral (A) and right anterior oblique (B) view of the right ventricular septum divided into nine regions and indicating the distribution of the origin of idiopathic ventricular arrhythmias, represented by red dots (successful ablation sites) and green dots (unsuccessful ablation sites).\
TV Sup: the superoseptal portion of the tricuspid valvular right ventricular region; TV Mid: the midseptal portion of the tricuspid valvular right ventricular region; TV Inf: the inferoseptal portion of the tricuspid valvular right ventricular region; Basal Sup: the superoseptal portion of the basal right ventricular region; Basal Mid: the midseptal portion of the basal right ventricular region; Basal Inf: the inferoseptal portion of the basal right ventricular region; Apical Sup: the superoseptal portion of the apical right ventricular region; Apical Mid: the midseptal portion of the apical right ventricular region; Apical Inf: the inferoseptal portion of the apical right ventricular region; His: largest His-bundle potential (yellow dot); CS: coronary sinus (blue dot).](pone.0067038.g001){#pone-0067038-g001}

ECG Measurements {#s2f}
----------------

Twelve-lead electrocardiograms recorded at a paper speed of 25 mm/s were available for all patients with PVCs/IVTs originating from the RV septum. The analysis of the ECG pattern was focusing on the following characteristics: (1) The QRS morphology of the PVCs/IVTs in all 12 leads, (2) the duration of the QRS complex, (3) the site of R-wave transition in the precordial leads (The transition zone is where the QRS complex changes from predominately negative to predominately positive and the R/S ratio becomes \>1), (4) the QS pattern in the precordial leads, (5) the axis deviation. Normal QRS axis is from around −30 to +90 degrees. More negative than −30 degrees is called left axis deviation. More positive than +90 degrees is called right axis deviation.

Pace Mapping Study {#s2g}
------------------

The pace mapping study was performed in the 10 control subjects. A 7-F quadripolar catheter was used. A single electrical stimulus was delivered during the end diastole in a bipolar fashion at an output just greater than the diastolic threshold from the distal electrode pair (with the distal electrode as the cathode). The catheter sites were confirmed by multi-plane fluoroscopy, and pacing was performed at these segments of the RV septum in each patient ([Figure 1A](#pone-0067038-g001){ref-type="fig"}). The pacing protocol was performed after a written informed consent was obtained.

Follow-Up {#s2h}
---------

After RFCA, all patients underwent a 48-hour ECG monitoring. Holter was carried out 1 week after RFCA. Patients were not given any antiarrhythmic drugs after RFCA, and underwent Doppler color echocardiography and Holter examination 3 and 6 months after RFCA. ECG, echocardiography and 24-hour ECG monitoring were performed whenever the patient had symptoms suggestive of recurrence of VAs.

Statistical Analysis {#s2i}
--------------------

All values were expressed as mean value ± standard deviation (SD). The continuous variables were compared with a Student's t-test for two groups and with analysis of variance (ANOVA) for \>2 groups. The categorical data were compared with a Fisher's exact test. The sensitivity, specificity, and positive and negative predictive accuracies of the ECG characteristics to localize the site of origin of PVCs/IVTs were calculated. All tests were 2-tailed, and a value of P\<0.05 was considered statistically significant.

Results {#s3}
=======

Study Population {#s3a}
----------------

Among patients with PVCs/IVTs, the incidence of VAs originating from the RV septum was 5% (total 29 patients, 18 men and 11 women; mean age 50.3±21.3 years (range 8--80 years). The clinical characteristics of the 29 patients included in the study are shown in [Table 1](#pone-0067038-t001){ref-type="table"}. The past medical history was significant for hypertension in eight patients, diabetes in four patients. Symptoms consisted of palpitations (100%), presyncope (3.4%), syncope (3.4%), and chest pain (17.2%). The median duration of symptoms prior to the ablation procedure was 26.5 months (range 4--144). All patients in this study had failed prior antiarrhythmic therapy with 1.6±0.6 drugs, including amiodarone therapy in 6 patients (20.7%). No patients had a family history of sudden cardiac death, ventricular tachycardia, or cardiomyopathy. The mean left ventricular ejection fraction (LVEF) was 62.0±3.2%, and the left ventricular end-diastolic internal diameter was 45.9±2.2% mm (one patient with a markedly dilated left ventricle). No abnormalities suggestive of arrhythmogenic right ventricular cardiomyopathy were found by ECG and echocardiography and MRI and right ventricular contrast angiography in any of the patients.

10.1371/journal.pone.0067038.t001

###### Baseline patient characteristics.

![](pone.0067038.t001){#pone-0067038-t001-1}

  Patient       Age(y)     Sex   PVC count(number/24 h)          Symptoms          Symptom duration(M)               AADs used                    Comorbidities        LVEF(%)    LVEDd(mm)
  ----------- ----------- ----- ------------------------ ------------------------ --------------------- ------------------------------------ ------------------------ ---------- -----------
  1               32        M            33120                 palpitation                  6                 Beta-blocker,Propafenone                 none               61         45
  2               52        F            21637                 palpitation                 31                       Beta-blocker                       none               59         49
  3               17        M            16283                 palpitation                  6                       Beta-blocker                       none               68         41
  4               62        F            10328                 palpitation                  6                       Beta-blocker                   hypertension           60         46
  5               17        M            21862                 palpitation                 42                 Beta-blocker,Propafenone                 none               62         43
  6               59        F            16549                 palpitation                 36                 Beta-blocker,Propafenone                 none               59         48
  7               66        F            18280                 palpitation                 24                 Beta-blocker,Amiodarone         diabetes,hypertension       61         46
  8               54        F            25390                 palpitation                 24                       Beta-blocker                       none               60         49
  9               71        F            18544                 palpitation                 30                       Beta-blocker                   hypertension           62         45
  10              19        M            21862            Palpitationchest pain            60            Beta-blocker,Mexiletine,Amiodarone            none               66         46
  11              80        M            37618            Palpitation,presyncope            5                       Beta-blocker                   hypertension           57         49
  12              37        F            10261                 Palpitation                  6                       Beta-blocker                       none               63         45
  13              52        F            21063            Palpitation,chest pain           43                 Beta-blocker,Propafenone                 none               59         46
  14              74        M            16802                 Palpitation                  6                       Beta-blocker              Hypertension, diabetes      60         47
  15              73        M            16538                 palpitation                 19                 Beta-blocker,Propafenone                 none               65         46
  16              68        M            26982            palpitation,chest pain           10                 Beta-blocker,Amiodarone                  none               58         43
  17              63        M            20387                 palpitation                 30                 Beta-blocker,Propafenone                 none               66         45
  18              38        M            15724                 palpitation                 30                 Beta-blocker,Mexiletine                  none               67         42
  19              63        M            10663                 palpitation                  9                       Beta-blocker                       none               65         44
  20              19        F            32638            palpitation,chest pain           24                 Beta-blocker,Propafenone                 none               60         46
  21               8        M            36981             palpitation, syncope             5                       Beta-blocker                       none               62         49
  22              23        F            12220                 palpitation                 26                 Beta-blocker,Propafenone                 none               63         45
  23              54        M            17063                 palpitation                 42                 Beta-blocker,Amiodarone                  none               68         45
  24              70        M            19610                 palpitation                 36                 Beta-blocker,Amiodarone              hypertension           62         46
  25              32        M            11238                 palpitation                 18                       Beta-blocker                       none               67         44
  26              55        F            27817            palpitationchest pain            28                       Beta-blocker                     diabetes             61         48
  27              57        M            19627                 palpitation                 18                 Beta-blocker,Propafenone                 none               60         48
  28              68        M            25317                 palpitation                  4                       Beta-blocker                   hypertension           60         45
  29              76        M            11096                 palpitation                 144                Beta-blocker,Amiodarone         hypertension,diabetes       58         50
  Mean ± SD    50.3±21.3               20466±7734                                       26.5±26.9                                                                      62.0±3.2   45.9±2.2

Y = years, M = Months, AADs = antiarrhythmic drugs, LVEF = left ventricular ejection fraction, LVEDd = left ventricular end-diastolic internal diameter.

Baseline 24-Hour ECG Monitoring {#s3b}
-------------------------------

The mean PVC burden during the preoperative 24 h of ambulatory Holter monitoring was 20466±7734 (range 10261--37618): 20 patients (69.1%) had single isolated PVC, 5 patients (17.2%) had ventricular couplets, 1 patient (3.4%) had non sustained monomorphic VT (defined as ≧ 3 consecutive PVCs, duration ≦ 30 s), 3 patients (10.3%) had sustained monomorphic VT (duration ≧ 30 s) ([Table 1](#pone-0067038-t001){ref-type="table"}). The PVCs were monomorphic in all patients.

Electrophysiologic Findings and Effect of RFCA {#s3c}
----------------------------------------------

PVCs/IVTs arise from the RV septum in 29 patients, including 20 (69%) from the septal portion of the tricuspid valvular RV region (3 from right superoseptum, 15 from right midseptum, 2 from right inferoseptum), and 9 (31%) from the septal portion of the basal RV (1 from right superoseptum, 4 from right midseptum, 4 from right inferoseptum). No PVCs/IVTs originated from the septal portion of the apical RV. [Figure 1B](#pone-0067038-g001){ref-type="fig"} and [Table 2](#pone-0067038-t002){ref-type="table"} list the detailed VA origin from the RV septum. The PVCs/IVTs occurred spontaneously in 26 patients and was induced by bolus injection of isoproterenol (2 µg) in 3 patients during the electrophysiologic study. Twenty-two of 29 patients underwent the electrophysiologic study using Ensite NavX system or Carto XP system or Carto 3 system, and the remaining 7 patients using conventional mapping techniques. The local ventricular activation time recorded at successful ablation target sites that preceded the onset of the QRS complex was 30.4±5.4 ms ([Table 2](#pone-0067038-t002){ref-type="table"}). Successful RFCA in 27 patients could be achieved (93.1% acute procedural success). RFCA could not be applied in the remaining 2 patients because the best pace mapping site was close to the His bundle ([Figure 2](#pone-0067038-g002){ref-type="fig"}). No complications occurred during the mapping or ablation procedure. An average of 3.2±1.4 (range 2--7) radiofrequency energy applications were delivered with a mean total radiofrequency energy duration of 270.9±98.4 (range 62--516)s. The mean fluoroscopy time was 8.0±2.3 (range 1.8--11.4) min. Patients have been followed-up for 11.2±8.2 (range 3--36) months. One patient had recurrent VAs after an initially effective procedure. The transthoracic echocardiography demonstrated a decreased LVEDd 6 months after effective RFCA in the patient whose LVEDd was increased prior to ablation (Patient No. 21 in [Table 1](#pone-0067038-t001){ref-type="table"}). No right ventricular dilation, wall motion abnormalities, or ECG abnormalities (i.e., inverted T waves in the right precordial leads, epsilon wave) were found in any of these patients during follow-up. No patient died during follow-up.

![Example of a unsuccessful ablation of a premature ventricular contraction (PVC) originating from the superoseptal portion of the tricuspid valvular right ventricular region.\
No attempt at ablation was undertaken because the origin of the PVC was found to be near the His-bundle. (A) The surface ECG characteristic. (B) The local ventricular activation time recorded at the site that preceded the onset of the QRS complex was 41 ms. A sharp His electrogram at the site was recorded in sinus rhythm. (C) Pace map at the site. (D) The fluoroscopic position of the ablation catheter and the His-bundle catheter sites. The site of the origin of the PVC was just less than 1 cm superior to the His-bundle catheter. ABL, ablation catheter; RAO, right anterior oblique projection; LAO, left anterior oblique projection.](pone.0067038.g002){#pone-0067038-g002}

10.1371/journal.pone.0067038.t002

###### The RFCA outcome.

![](pone.0067038.t002){#pone-0067038-t002-2}

  Patient     Origin     Mappingtechnique   EAT(ms)    Pace mapping(12 lead concordance)          Ablationoutcome           RF lesionsprior tosuccess       Proceduralcomplication              Recurrent          Follow uptime (M)
  --------- ----------- ------------------ ---------- ----------------------------------- -------------------------------- --------------------------- -------------------------------- ------------------------- -------------------
  1           TV Sup         EAT+Pace          42                     10                              success                           3                             no                           no                     30
  2           TV Sup         EAT+Pace          31                     10                              success                           3                             no                           no                     18
  3           TV Sup         EAT+Pace          41                     12                              failure                          --                             no                           --                     21
  4           TV Mid         EAT+Pace          28                     10                              success                           2                             no                           no                      4
  5           TV Mid         EAT+Pace          28                     12                              success                           3                             no                           no                     11
  6           TV Mid         EAT+Pace          24                     12                              success                           2                             no                           no                     11
  7           TV Mid         EAT+Pace          28                     12                              success                           2                             no                           no                     18
  8           TV Mid         EAT+Pace          30                     12                              success                           3                             no                           no                     12
  9           TV Mid         EAT+Pace          27                     12                              success                           5                             no                           no                     12
  10          TV Mid         EAT+Pace          32                     12                              success                           2                             no                           yes                    11
  11          TV Mid         EAT+Pace          31                      9                              success                           2                             no                           no                     11
  12          TV Mid         EAT+Pace          34                     12                              success                           2                             no                           no                      3
  13          TV Mid         EAT+Pace          29                     12                              success                           3                             no                           no                      4
  14          TV Mid         EAT+Pace          22                     12                              success                           5                             no                           no                      3
  15          TV Mid         EAT+Pace          31                     11                              failure                          --                             no                           --                      6
  16          TV Mid         EAT+Pace          32                     11                              success                           4                             no                           no                      4
  17          TV Mid         EAT+Pace          32                     12                              success                           4                             no                           no                      6
  18          TV Mid         EAT+Pace          30                     11                              success                           7                             no                           no                      6
  19          TV Inf         EAT+Pace          30                     12                              success                           2                             no                           no                     24
  20          TV Inf         EAT+Pace          33                     12                              success                           3                             no                           no                      6
  21         Basal Sup       EAT+Pace          39                      9                              success                           3                             no                           no                      6
  22         Basal Mid       EAT+Pace          20                     12                              success                           2                             no                           no                     12
  23         Basal Mid       EAT+Pace          20                     12                              success                           3                             no                           no                     12
  24         Basal Mid       EAT+Pace          39                     12                              success                           3                             no                           no                     36
  25         Basal Mid       EAT+Pace          30                      9                              success                           7                             no                           no                     11
  26         Basal Inf       EAT+Pace          30                     12                              success                           2                             no                           no                     12
  27         Basal Inf       EAT+Pace          26                     11                              success                           3                             no                           no                      6
  28         Basal Inf       EAT+Pace          32                     12                              success                           4                             no                           no                      6
  29         Basal Inf       EAT+Pace          32                     12                              success                           2                             no                           no                      3
  Total                                     30.4±5.4               11.3±1.04               Procedural success rate: 93.1%            3.2±1.4            Proceduralcomplication rate: 0   Recurrent rate (%): 3.7       11.2±8.2

RFCA: radiofrequency catheter ablation; EAT: earliest activation time; TV Sup: the superoseptal portion of the tricuspid valvular right ventricular region; TV Mid: the midseptal portion of the tricuspid valvular right ventricular region; TV Inf: the inferoseptal portion of the tricuspid valvular right ventricular region; Basal Sup: the superoseptal portion of the basal right ventricular region; Basal Mid: the midseptal portion of the basal right ventricular region; Basal Inf: the inferoseptal portion of the basal right ventricular region.

ECG Characteristics {#s3d}
-------------------

### General characteristics {#s3d1}

All PVCs/IVTs arising from the RV septum had an rS or QS pattern in lead V1 and displayed a left bundle branch block morphology ([Figures 2](#pone-0067038-g002){ref-type="fig"}--[7](#pone-0067038-g007){ref-type="fig"} and [Table 3](#pone-0067038-t003){ref-type="table"}). All PVCs/IVTs showed a monophasic R pattern in lead I, 86.2% (25/29) PVCs/IVTs had a QS or qs pattern in lead aVR, and 79.3% (23/29) PVCs/IVTs had a monophasic R pattern in lead aVL. The duration of the QRS complex of the PVCs/IVTs was132±10 (range 110--150) ms. The precordial R-wave transition occurred in or earlier than lead V3 in 14 patients, and later than lead V3 in 15 patients (earlier than lead V2 in 2 patients, between lead V2 and V3 in 6 patients, in lead V3 in 6 patients, between lead V3 and V4 in 6 patients, between lead V4 and V5 in 4 patients, between lead V5 and V6 in 2 patients, in lead V6 in 1 patient, later than lead V6 in 2 patients).

![Representative 12-lead electrocardiograms of premature ventricular contractions originating from the right ventricular septum.\
A: the superoseptal portion of the tricuspid valvular right ventricular region; B: the midseptal portion of the tricuspid valvular right ventricular region; C: the inferoseptal portion of the tricuspid valvular right ventricular region; D: the superoseptal portion of the basal right ventricular region; E: the midseptal portion of the basal right ventricular region; F: the inferoseptal portion of the basal right ventricular region; G: Schematic right anterior oblique (RAO) view of the right ventricular septum displaying the sites of origin of the PVC/IVTs, represented by the red dots. His: largest His-bundle potential (yellow dot); CS: coronary sinus (blue dot).](pone.0067038.g003){#pone-0067038-g003}

![Example of a successful ablation of a premature ventricular contraction (PVC) originating from the inferoseptal portion of the tricuspid valvular right ventricular region.\
(A) The surface ECG characteristic. (B) The local ventricular activation time recorded at the successful ablation site that preceded the onset of the QRS complex was 33 ms. (C) Pace map at the ablation site. (D) The fluoroscopic position of the ablation catheter site. (E) Green dot indicates site of RF application under the guide of Carto 3. ABL, ablation catheter; RAO, right anterior oblique projection; LAO, left anterior oblique projection; Septal, right ventricular septum; FW, right ventricular free wall; TA, tricuspid annulus.](pone.0067038.g004){#pone-0067038-g004}

![Example of a successful ablation of a premature ventricular contraction (PVC) originating from the midseptal portion of the tricuspid valvular right ventricular region.\
(A) The surface ECG characteristic. (B) The local ventricular activation time recorded at the successful ablation site that preceded the onset of the QRS complex was 31 ms. (C) Pace map at the ablation site. (D) The fluoroscopic position of the ablation catheter and the His-bundle catheter sites. (E) Red dot indicates site of RF application under the guide of Ensite NavX. ABL, ablation catheter; RAO, right anterior oblique projection; LAO, left anterior oblique projection.](pone.0067038.g005){#pone-0067038-g005}

![Example of a successful ablation of a premature ventricular contraction (PVC) originating from the midseptal portion of the basal right ventricular region.\
(A) The surface ECG characteristic. (B) The local ventricular activation time recorded at the successful ablation site that preceded the onset of the QRS complex was 20 ms. (C) Pace map at the ablation site. (D) The fluoroscopic position of the ablation catheter site. (E) Termination of PVCs within 3 seconds during RF application at the site. ABL, ablation catheter; RAO, right anterior oblique projection; LAO, left anterior oblique projection.](pone.0067038.g006){#pone-0067038-g006}

![Example of a successful ablation of a premature ventricular contraction (PVC) originating from the inferoseptal portion of the basal right ventricular region.\
(A) The surface ECG characteristic. (B) The local ventricular activation time recorded at the successful ablation site that preceded the onset of the QRS complex was 32 ms. (C) Pace map at the ablation site. (D) The fluoroscopic position of the ablation catheter site. ABL, ablation catheter; RAO, right anterior oblique projection; LAO, left anterior oblique projection.](pone.0067038.g007){#pone-0067038-g007}

10.1371/journal.pone.0067038.t003

###### 12-lead ECG characteristics of PVCs/IVTs originating from the right ventricular septum.

![](pone.0067038.t003){#pone-0067038-t003-3}

  Pt     origin     QRS axis   QRS complex morphology   TransitionZone   QRS duration(ms)                                                          
  ---- ----------- ---------- ------------------------ ---------------- ------------------ ---- ---- ---- --- ---- ---- ---- ------- ----- ------- -----
  1      TV Sup       left               rS                   rS                Rs          R    R    R    R   QS   R    R     Rs      R    V2∼V3   130
  2      TV Sup      normal              rS                   rS                RS          R    R    R    R   QS   qr   R     Rs      R     V3     130
  3      TV Sup      normal              rS                   RS                Rs          R    R    R    R   QS   m    R     Rs      R    V2∼V3   150
  4      TV Mid       left               QS                   QS                rS          R    R    R    R   QS   qR   Rs    rS     rS    V3∼V4   130
  5      TV Mid       left               QS                   Rs                Rs          R    R    R    R   QS   R    RS    RS     RS    V2∼V3   120
  6      TV Mid      normal              QS                   rS                RS          R    R    R    R   QS   R    R    rs r'    R    V2∼V3   140
  7      TV Mid       left               QS                   RS                Rs          R    R    R    R   QS   r    R     rs     Rs    V2∼V3   140
  8      TV Mid       left               QS                   QS                Rs          R    R    R    R   QS   qr   R     Rs     Rs    V3∼V4   130
  9      TV Mid       left               QS                   rS                rS          Rs   R    R    R   QS   R    R     qs     rs    V3∼V4   130
  10     TV Mid       left               QS                   QS                RS          R    R    R    R   QS   R    R     qs     rs    V3∼V4   130
  11     TV Mid       left               QS                   QS                RS          R    R    R    R   QS   R    R     qRs    qRs    V3     110
  12     TV Mid       left               QS                   rS                rS          R    R    R    R   QS   R    R     rS     rs    V3∼V4   150
  13     TV Mid       left               QS                   rS                Rs          R    R    R    R   QS   R    R     QS     rs    V2∼V3   120
  14     TV Mid       left               QS                   rS                RS          R    R    R    R   QS   R    Rs    rS     rS     V3     140
  15     TV Mid       left               QS                   rS                RS          R    R    R    R   QS   R    Rs    rS     rS     V3     130
  16     TV Mid      normal              QS                   QS                rS          R    R    R    R   QS   qR   R     Rs     Rs    V3∼V4   120
  17     TV Mid       left               QS                   rS                RS          R    R    R    R   QS   R    R     rs     Rs     V3     140
  18     TV Mid       left               QS                   Rs                R           R    R    R    R   QR   R    Rs    rS     rS    V1∼V2   140
  19     TV Inf      normal              QS                   R                 R           R    R    R    R   QS   R    rs    QS     rs    V1∼V2   150
  20     TV Inf       left               QS                   rS                rs          rs   rs   rs   R   QS   R    rs    rS     rS     V3     120
  21    Basal Sup     left               rS                   rS                rS          rS   rS   R    R   QS   R    rs    rS     rS    V5∼V6   130
  22    Basal Mid    normal              QS                   QS                QS          rS   R    R    R   QS   qs   R      R      R    V4∼V5   120
  23    Basal Mid     left               QS                   QS                QS          rS   R    R    R   qs   R    rS    QS     rS    V4∼V5   120
  24    Basal Mid     left               QS                   QS                rS          rS   R    R    R   qs   R    rS    rS     rS    V4∼V5   120
  25    Basal Mid     left               QS                   QS                QS          QS   rs   rs   R   QS   R    rS    rS     rS    V5∼V6   140
  26    Basal Inf     left               QS                   QS                QS          rS   rS   rS   R   QS   R    rS    QS     QS    \> V6   130
  27    Basal Inf     left               rS                   rS                rS          rS   rS   rs   R   qr   R    rS    rS     rS     V6     140
  28    Basal Inf     left               QS                   QS                QS          QS   QS   QS   R   R    R    QS    QS     QS    \> V6   140
  29    Basal Inf     left               QS                   rS                rS          rS   R    R    R   qr   R    rS    rS     rS    V4∼V5   140

Capital letters (Q,R,S) refer to relatively high-amplitude waves (\>5 mm). Conversely, lowercase letters (q,r,s) refer to relatively low-amplitude waves (\<5 mm).

### Comparison between PVCs/IVTs arising from the tricuspid valvular and basal RV septum {#s3d2}

There was no significant difference in QRS duration between the PVCs/IVTs arising from the tricuspid valvular and basal RV septum. The precordial R-wave transition occurred in lead V4 or earlier (≦V4) in all of the PVCs/IVTs arising from the tricuspid valvular RV septum, and all patients with the PVCs/IVTs arising from the basal RV septum had a later precordial R-wave transition (\>V4) ([Figure 8](#pone-0067038-g008){ref-type="fig"} and [Table 4](#pone-0067038-t004){ref-type="table"}). The earlier precordial R-wave transition (≦V4) has a sensitivity of 100%, a specificity of 100%, a negative predictive value of 100%, and a positive predictive value 100% to predict the tricuspid valvular RV septal origin of PVCs/IVTs ([Table 5](#pone-0067038-t005){ref-type="table"}).

![Differences in (A) QS pattern in lead V1 between PVCs/IVTs arising from the RV superoseptum and mid-inferoseptum and (B) precordial R-wave transition occurring by lead V4 between PVCs/VTs arising from the tricuspid valvular and basal right ventricular septum.](pone.0067038.g008){#pone-0067038-g008}

10.1371/journal.pone.0067038.t004

###### Comparison of ECG characteristics between PVCs/VTs arising from the tricuspid valvular and basal right ventricular septum, between PVCs/IVTs arising from the RV superoseptum and mid-inferoseptum.

![](pone.0067038.t004){#pone-0067038-t004-4}

  Group               n      QS pattern in precordial leads      Precordial R-wave transition                                                          
  ------------------ ---- ------------------------------------- ------------------------------ --- --- --------------------------------------- --- --- ---
  TV Septal           20                   17                                 5                 0   0   20[\*\*](#nt106){ref-type="table-fn"}   0   0   0
  Basal Septal        9                     7                                 7                 5   2                     0                     4   2   3
  Superoseptum        4                     0                                 0                 0   0                     3                     0   1   0
  Mid-inferoseptum    25   24[\*](#nt105){ref-type="table-fn"}                12                5   2                    17                     4   1   3

TV Septal: the tricuspid valvular right ventricular septum; Basal Septal: the basal right ventricular septum;

p\<0.001 Superoseptum versus Mid-inferoseptum,

p\<0.005 TV Septal versus Basal Septal.

10.1371/journal.pone.0067038.t005

###### The sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) to identify the precise origin of PVCs/IVTs from the right ventricular (RV) septum.

![](pone.0067038.t005){#pone-0067038-t005-5}

  ECG variables                                                                                               Sensitivity (%)   Specificity (%)   NPV (%)   PPV (%)
  ---------------------------------------------------------------------------------------------------------- ----------------- ----------------- --------- ---------
  Precordial R-wave transition ≤V4 in patients with PVCs/IVTs arisingfrom the tricuspid valvular RV septum          100               100           100       100
  QS pattern in lead V1 in patients with PVCs/IVTs arising from theRV mid-inferoseptum                             96.00              100          80.00      100

### Comparison between PVCs/IVTs arising from the RV superoseptum and mid-inferoseptum {#s3d3}

PVCs/IVTs arise from the RV septum in 29 patients, including 4 (13.8%) from the RV superoseptum and 25 (86.2%) from the RV mid-inferoseptum. There was no significant difference in QRS complex duration between the PVCs/IVTs arising from the RV superoseptum and mid-inferoseptum. A QS pattern in lead V1 was observed in 96% (24/25) of the PVCs/IVTs arising from the RV mid-inferoseptum, and an rS pattern in lead V1 was observed in all of PVCs/IVTs arising from the RV superoseptum ([Figure 8](#pone-0067038-g008){ref-type="fig"} and [Table 4](#pone-0067038-t004){ref-type="table"}). The QS pattern in lead V1 has a sensitivity of 96%, a specificity of 100%, a positive predictive value 100%, and a negative predictive value of 80% to predict the RV mid-inferoseptal origin of PVCs/IVTs ([Table 5](#pone-0067038-t005){ref-type="table"}). When the origin of the PVCs/IVTs shifted from inferoseptum to midseptum to superoseptum of the RV ([Figure 3](#pone-0067038-g003){ref-type="fig"}): R wave amplitude increased and S wave amplitude decreased in leads II, III, aVF and V2--V6; R wave amplitude decreased in lead aVL; QS amplitude increased in lead aVR.

### Comparison among PVCs/IVTs arising from the RV septum, RV free wall and RV outflow tract (RVOT) {#s3d4}

The QRS duration in PVCs/IVTs arising from the RV septum were significantly shorter compared with the arrhythmias arising from the RV free wall (132±10 ms VS 159±12 ms, P\<0.001 ) and RVOT (132±10 ms VS 142±14 ms, P\<0.001) ([Table 6](#pone-0067038-t006){ref-type="table"}). Right axis deviation was noted in 87.4% (76/87) PVCs/IVTs in the RVOT group, and left axis deviation was noted in 79.3% (23/29) PVCs/IVTs in the RV septum group and in 71.1% (27/38) PVCs/IVTs in the RV free wall group. QS pattern and rS pattern in lead V1 were observed in 82.8% (24/29) and 17.2% (5/29) of the PVCs/IVTs arising from the RV septum, versus 2.3% (2/87) and 97.7% (85/87) of the PVCs/IVTs arising from the RVOT (P\<0.001 for both) and 5.3% (2/38) and 94.7% (36/38) of PVCs/IVTs arising from the RV free wall (P\<0.001 for both) ([Figure 9](#pone-0067038-g009){ref-type="fig"} and [Table 6](#pone-0067038-t006){ref-type="table"}). In the RVOT group, 86/87 (98.9%) had a monophasic R pattern in all three inferior leads (II, III, aVF) ([Figure 9](#pone-0067038-g009){ref-type="fig"} and [Table 6](#pone-0067038-t006){ref-type="table"}). Only 1/29 (3.5%) in the RV septum group and 2/38 (5.3%) in the RV free wall group had a monophasic R pattern in all inferior leads (98.9% VS 3.5%, 98.9% VS 5.3%; both P\<0.001) ([Figure 9](#pone-0067038-g009){ref-type="fig"} and [Table 6](#pone-0067038-t006){ref-type="table"}). The monophasic R pattern in all inferior leads has a sensitivity of 98.9%, a specificity of 95.5%, a positive predictive value 96.6%, and a negative predictive value of 100.00% to predict the RVOT origin of PVCs/IVTs ([Table 7](#pone-0067038-t007){ref-type="table"}). The QS pattern in lead V1 has a sensitivity of 82.8%, a specificity of 94.7%, a positive predictive value 92.3%, and a negative predictive value of 87.8%, and the QRS duration of ≦143.5 ms has a sensitivity of 89.7%, a specificity of 89.5%, a positive predictive value 86.7%, a negative predictive value of 91.9%and to predict the RV septum origin of PVCs/IVTs ([Figure 10](#pone-0067038-g010){ref-type="fig"} and [Table 7](#pone-0067038-t007){ref-type="table"}).

![Differences in (A) Monophasic R pattern in three inferior leads between PVCs/IVTs arising from the right ventricular outflow tract (RVOT) and not arising from the right ventricular outflow tract (NRVOT) and (B) QS pattern in lead V1 between PVCs/VTs arising from the RV septum (Septal) and free wall (FW).](pone.0067038.g009){#pone-0067038-g009}

![Distribution of QRS duration in patients with idiopathic PVC/VTs arising from the right ventricular septum (Septal) and free wall (FW).\
The QRS duration of ≦143.5 suggested the right ventricular septum origin with high sensitivity and specificity.](pone.0067038.g010){#pone-0067038-g010}

10.1371/journal.pone.0067038.t006

###### Comparison of ECG characteristics among PVCs/VTs arising from the right ventricular (RV) septum, RV free wall and RV outflow tract (RVOT).

![](pone.0067038.t006){#pone-0067038-t006-6}

  Origin       n                 QRS duration (ms)                 QRS axis   Monophasic R pattern in three inferior leads   QRS pattern in lead V1       Precordial R-wave transition                                                                                            
  ----------- ---- ---------------------------------------------- ---------- ---------------------------------------------- ------------------------ --------------------------------------- ------------------------------------- ------------------------------------ ---- ---- ----
  Septum       29                    132.1±10.5                       23                           0                                   6                                1                                      5                                    24                   8    6    15
  Free wall    38    159.4±12.1[a](#nt107){ref-type="table-fn"}       27                           1                                   10                               2                     36 [a](#nt107){ref-type="table-fn"}   2 [a](#nt107){ref-type="table-fn"}   0    6    31
  RVOT         87   142.4±14.4[a b](#nt107){ref-type="table-fn"}      0          76 [a b](#nt107){ref-type="table-fn"}                 11             86 [a b](#nt107){ref-type="table-fn"}   85 [a](#nt107){ref-type="table-fn"}   2 [a](#nt107){ref-type="table-fn"}   10   35   37

p\<0.001 versus RV Septum,

p\<0.001 versus RV Free wall.

10.1371/journal.pone.0067038.t007

###### The sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) to identify the precise origin of PVCs/IVTs arising from the right ventricular outflow tract (RVOT) and not arising from the RVOT (NRVOT) and PVCs/VTs arising from the RV septum and free wall.

![](pone.0067038.t007){#pone-0067038-t007-7}

  ECG variables                                                                                        Sensitivity(%)   Specificity(%)      NPV(%)         PPV(%)
  --------------------------------------------------------------------------------------------------- ---------------- ---------------- --------------- -------------
  Monophasic R pattern in all three inferior leads in patients with PVCs/IVTs arising from the RVOT     98.9(86/87)      95.5(64/67)     100.00(64/65)   96.6(86/89)
  QS pattern in lead V1 in patients with PVCs/IVTs arising from the RV septum                           82.8(24/29)      94.7(36/38)      87.8(36/41)    92.3(24/26)
  QRS duration of ≦143.5 ms in patients with PVCs/IVTs arising from the RV septum                       89.7(26/29)      89.5(34/38)      91.9(34/37)    86.7(26/30)

Pace Mapping Study {#s3e}
------------------

Because it was difficult to position the catheter in the superoseptal portion of the apical RV region, pace mapping at the region was not performed. The pace mapping was performed at the other 8 segments of the RV septum. The characteristics of the QRS morphology during pacing from the RV septum in 10 subjects were almost identical with those of the PVCs/IVTs arising from the RV septum ([Figure 11](#pone-0067038-g011){ref-type="fig"}). There existed some distinctive ECG characteristics during pacing in 10 subjects ([Figure 11](#pone-0067038-g011){ref-type="fig"}): 1) During pacing from superoseptum to inferoseptum of RV and from tricuspid valvular RV septum to apical RV septum, R wave amplitude was more lessening and S wave amplitude was more increasing in leads II, III, aVF and V4--V6. 2) During pacing from superoseptum to inferoseptum of RV, R wave amplitude was more increasing and Q wave amplitude was more lessening in lead aVL. 3) A rS pattern in lead V1 was observed only when pacing at the superoseptal portion of the tricuspid valvular RV region, and a QS pattern in lead V1 was always recorded when pacing at the other sites of the RV septum. During pacing from tricuspid valvular RV septum to apical RV septum, the number of precordial leads displaying the QS pattern was more increasing, and the number of precordial leads displaying the R or RS pattern was more decreasing ([Figure 11](#pone-0067038-g011){ref-type="fig"}).

![Pace mapping from the different regions of the right ventricular septum.\
A: Schematic right anterior oblique (RAO) view of the right ventricular septum displaying the different pacing sites represented by the red dots; B: The characteristics of the QRS morphology during pacing at the different regions of the right ventricular septum. 1, the superoseptal portion of the tricuspid valvular right ventricular region; 2, the midseptal portion of the tricuspid valvular right ventricular region; 3, the inferoseptal portion of the tricuspid valvular right ventricular region; 4: the superoseptal portion of the basal right ventricular region; 5: the midseptal portion of the basal right ventricular region; 6: the inferoseptal portion of the basal right ventricular region; 7, the midseptal portion of the apical right ventricular region; 8, the inferoseptal portion of the apical right ventricular region.](pone.0067038.g011){#pone-0067038-g011}

Discussion {#s4}
==========

Main Findings {#s4a}
-------------

The study demonstrated for the first time that 5% of PVCs/IVTs had an origin at the RV septum, and that the septal portion of the tricuspid valvular RV region was the preferential site of origin, but the site of origin also could be located at the septal portion of the basal RV region. We note different ECG characteristics of PVCs/IVTs originating from the different portions of the RV septum which were confirmed by the pace mapping study and demonstrate that RFCA can be performed safely with good long-term success in preventing symptomatic VAs.

Site-specific ECG Characteristics and their Proposed Mechanisms {#s4b}
---------------------------------------------------------------

Prior studies described VAs originating from the tricuspid annulus and RV septum near the His-bundle in patients without structural heart disease [@pone.0067038-Satish1]--[@pone.0067038-Yamauchi1]. We and other investigators have recently demonstrated that QRS duration, R-wave transition in the precordial leads, QS pattern in lead V1, and polarity of the QRS complex in the inferior leads were useful to distinguish between PVCs/IVTs originating from the septal portion and free wall of tricuspid annulus [@pone.0067038-Tada1], [@pone.0067038-YueChun1]. A monophasic tall R pattern in lead I, low R wave in leads II and aVF, particularly lower R wave in lead III than in lead II, R wave in lead aVL, relatively narrow QRS duration, QS pattern in lead V1, and tall R wave in V5 and V6 suggest the PVCs/IVTs origin from the RV septum near the His-bundle [@pone.0067038-Yamauchi1]. Although several studies have reported the PVCs/IVTs arising from the tricuspid annulus and RV septum near the His-bundle, none have systemically determined the prevalence and ECG characteristics of PVCs/IVTs arising from the different sites of the RV septum, based on as many patients as in this study. In the present study, the relatively early precordial R wave transition by lead V4 help us to differentiate the tricuspid valvular septum from the basal RV septal site of origin. Because the origin of VAs in the tricuspid valvular septum was located in the more posterior portion of the RV than that in the basal septum of the RV, more distant from the precordial electrodes, the myocardium near the focus was depolarized in a direction more toward these electrodes. This could account for the earlier precordial R-wave transition (≦V4) in the PVCs/IVTs arising from the tricuspid valvular septum than the basal RV septum. In the present study, another interesting finding was that when the origin of the PVCs/IVTs shifted from inferoseptum to midseptum to superoseptum of the RV, R wave amplitude increased and S wave amplitude decreased in leads II, III, aVF and V2--V6, R wave amplitude decreased in lead aVL, and QS amplitude increased in lead aVR. Because the origin of the PVCs/IVTs arising from the RV inferoseptum was located on the right inferior side of the heart, the myocardium would be depolarized in a direction toward the anode of leads aVL, away from the inferior leads, which might account for the findings: lower R wave and greater S wave amplitude in the inferior leads, and greater R wave amplitude in the lead aVL; the origin of the PVCs/IVTs arising from the RV superoseptum was located on the right superior side of the heart, the myocardium would be depolarized in a direction toward the inferior leads, away from the lead aVR and aVL, which might account for the findings: greater R wave and smaller S wave amplitude in the inferior leads, greater QS amplitude in lead aVR, smaller R amplitude in lead aVL. In the present study, the QS pattern in lead V1 and QRS duration were found to be useful to distinguish PVCs/IVTs origin in the RV septum or the RV free wall. Because the magnitude of the initial ventricular force is expected to be much greater in the left ventricle than in the RV, the mean initial QRS vector would be directed to the left posterior and away from the electrode of lead V1 on the horizontal plane, which might predominantly result in a QS pattern in PVCs/IVTs arising from the RV septum. When the VAs focus is located at the RV septum, both ventricles would be activated almost simultaneously, which might result in a shorter QRS duration. In the present study, s or S wave in the inferior leads, particularly in lead III was observed more often PVCs/IVTs arising from the RV septum than that arising from the RVOT. In contrast, the monophasic R pattern in all of the inferior leads was observed more often PVCs/IVTs arising from the RVOT than that arising from the RV septum. Because the RV septum is positioned to the right and inferior to the RVOT. Therefore, in PVCs/IVTs arising from the RV septum, it would be directed more to the left and superiorly than in PVCs/IVTs arising from the RVOT, which may account for the rarities of a monophasic R pattern in all of the inferior leads in PVCs/IVTs arising from the RV septum.

Radiofrequency Ablation {#s4c}
-----------------------

Previous studies have shown that PVCs/IVTs originating from the septal portion of tricuspid annulus and RV septum near the His-bundle can be successfully ablated [@pone.0067038-Satish1]--[@pone.0067038-Yamauchi1]. In the present study, we demonstrated that RFCA was effective for eliminating PVCs/IVTs arising from the RV septum. Twenty-seven of 29 patients with PVCs/IVTs arising from the RV septum were successfully ablated (93.1% acute success). In the remaining 2 patients no attempt at ablation was undertaken because the origin of the PVCs/IVTs was found to be parahisian. One patient had recurrent ventricular arrhythmia after successful RFCA during a mean follow-up period of 11.2 months. No significant complications were observed in our patient group confirming the safety of the procedure. Although clinical application of RF energy in the RV septum has proven relatively safe, much care must be taken to avoid the complications, such as atrioventricular node conduction block.

Study Limitations {#s4d}
-----------------

No abnormalities suggestive of arrhythmogenic right ventricular cardiomyopathy were found by ECG and echocardiography and MRI and right ventricular contrast angiography in any of the patients with the RV septal VAs in the present study. No ECG and echocardiography changes suggestive of arrhythmogenic right ventricular cardiomyopathy were seen during follow up. However, a signal-averaged ECG or endomyocardial biopsy was no performed. Therefore, we could not have completely excluded the possibility of a concealed form of arrhythmogenic right ventricular cardiomyopathy. However, we believe the data presented strongly suggests that the arrhythmias described were truly idiopathic. To increase the accuracy of our study, our results need to be confirmed in additional long-term follow-up.

Conclusions {#s4e}
-----------

We identified a group of patients with PVCs/IVTs arising from the RV septum. ECG characteristics of PVCs/VTs originating from the different portions of the RV septum are different, and can help regionalize the origin of these arrhythmias. RFCA at the RV septum was effective and safe for the PVCs/IVTs.
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